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Neonatal respiratmy failure, no matter what the cause, may 
not always respond to standard mechanical ventilation techniques. 
F,xtracorporeal membrane oxygenation has emerged over the last 
15 years as an adjunct to the treatment of these babies with a 
greater than 80% survival nationwide. 
Limited resources and personnel costs can be prohibitive, 
forcing regionalization of extracorporeal membrane oxygenation 
( ECMO) centers. Geographic distance from a center should not 
limit its potential application, however. Familiarity with the 
technique, early application of the modality and the availability of 
medical air transport, allows for referral and transfer of neonates 
over great distances with excellent results and outcomes. 
We present a case of respiratory failure in a neonate trans-
ported 2,500 miles for ECMO therapy with an excellent outcome 
and a rapid return home. 
Introduction 
Neonatal respiratory failure secondary to meconium aspira-
tion, sepsis, diaphragmatic hernia and respiratory distress syn-
drome can be successfully treated with extracorporeal membrane 
oxygenation (ECMO) with an 80% survival and minimal mortal-
ityi-8. The treatment of neonatal respiratory failure with prolonged 
veno-arterial extracorporeal oxygenation is a considerable under-
taking, however, and requires a significant commitment on the 
part of those involved, with continuous nursing, technician and 
physician coverage for what may be many weeks. A consistent 
demand for such service and a significant population base of 
potential patients is needed to keep an ECMO team optimally 
trained, and the required equipment used in order to be cost-
effective. Because of these constraints, ECMO centers have 
become regionalized, with many major metropolitan teaching 
hospitals now having a 24-hour on-call ECMO team treating two 
or more neonates a month. 
Although it may be possible to document the periodic need 
for ECMO in various locales, limited resources and personnel 
make the creation of an ECMO service economically infeasible at 
many medical centers. The presence of an efficient, on-call, 
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medical air-transport system, especially when dealing with great 
distances, makes the need for a low-volume, high-cost local 
ECMO center less critical. Such medical air-transport has been 
shown to optimize care for neonatal and pediatric patients at 
regional medical centers, regardless of distance, in a number of 
disease states, including respiratory failure9-13 . 
We present a case of a Hawaii newborn who had progressive 
respiratory failure and pulmonary hypertension due to severe 
meconium aspiration, and who was successfully transferred by 
military medical evacuation aircraft over 2,500 miles from Hono-
lulu to Los Angeles and UCLA Medical Center for ECMO with 
an excellent outcome. 
Case Study 
A 3.65 kilogram infant was born by spontaneous vaginal 
delivery 2 hours after rupture of membranes, to a healthy gravida 
1, para 0 woman who had had good prenatal care at 42 weeks' 
gestation. Delivery was complicated by the cord around the 
infant's neck, meconium staining of the skin and aspiration of 
meconium. Oro-tracheal suctioning at delivery revealed small 
amounts of blood-tinged meconium from below the vocal cords 
on 4 tries. Apgar scores were 4, 6, and 8 at 1, 3 and 10 minutes 
respectively. The baby developed progressive cardiopulmonary 
insufficiency requiring intubation with an Fi00 of 1.00, pressure 
settings of37 /9 em Hp, and a ventilatory rate of 120/min in order 
to maintain a p00 above 40 torr. Serial chest roentgenograms 
showed progressive opacification of both lung fields with wors-
ening bilateral air bronchograms. The baby required dopamine 
and dobutarnine infusions to support blood pressure and continuous 
i.v. fentanyl citrate for sedation. 
At this point, the neonatology physicians communicated with 
the UCLA ECMO team regarding transfer to UCLA Medical 
Center for evaluation and for ECMO should the baby's condition 
continue to deteriorate. Intracranial hemorrhage and cardiac struc-
tural abnormalities were ruled out by ultrasound study in Hawaii 
prior to transport. Arrangements were made for air evacuation to 
Los Angeles by military air ambulance. The infant was accompa-
nied by a neonatologist and a medical flight nurse in accordance 
with American Academy of Pediatrics guidelines 14 • 
The patient arrived in Los Angeles at 37 hours of age after a 
6-hour flight. At that time she weighed 4.18 kg, a 0.53 kg (15%) 
increase in weight as a result of vigorous fluid resuscitation 
necessary to maintain reasonable cardiopulmonary perfusion pa-
rameters. Dopamine (15 meg/kg/min) and dobutamine (17 meg/ 
kg/min) were required to maintain a systolic blood pressure of 65 
and a heart rate of 120 beats per minute. Arterial blood gas on 
ventilator settings of Fi02 -1.00, rate 80/min and pressures of 34/ 
4 em Hp resulted in a pH of 7 .52, pC02 31 torr and p02 49 torr. 
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The oxygenation index (OJ) was calculated at 0.41 and the 
alveolar-arterial oxygen difference (AaDO,) was 633 torr. How-
ever, conservative medical management was not successful in 
reversing the pulmonary hypertension and respiratory failure. 
Therefore, the patient was placed on ECMO at 57 hours of life. 
After initiation of ECMO, ventilator settings were immediately 
reduced to Fi02 - 0.30, rate 15/min and pressures of24/14 em Hp. 
Blood gas results showed an arterial oxygen saturation of 99 to 
l 00% with a mixed venous saturation of 80%, documenting good 
oxygen delivery and normal peripheral tissue oxygen extraction. 
ECMO flows approximating 80% partial cardiopulmonary bypass 
were maintained for 24 hours; then the infant was rapidly weaned 
as she demonstrated decreasing pulmonary hypertension and 
improving pulmonary function at ventilator settings while at rest. 
The infant was removed from ECMO support after 66 hours, 
gradually weaned off the ventilator overthe next 72 hours and then 
extubated. 
On day 21 oflife, the infant and her parents returned to Hawaii 
via commercial air transport and without incident. The infant 
continued to do well on local follow-up in Hawaii 2 years later. 
Discussion 
The treatment of respiratory failure with partial cardiopulmo-
nary bypass or Extracorporeal Membrane Oxygenation originated 
at the University of California, Irvine, under Robert Bartlett MD 
and associates in the early 1970s. Initial trials ofECMO took place 
on severely ill patients with unresponsive respiratory failure in all 
age groups from premature neonates to adults. The early studies 
showed a survival advantage only in newborns near parturition. 
However, premature infants had a high incidence of intracranial 
hemorrhage while on systemic anticoagulation. Adults showed no 
improvement in survival when ECMO was applied instead of 
standard mechanical ventilatory management at that time. 
The indications and contraindications for ECMO (Table l ) 
were derived from the early experience of Bartlett and others who 
began using ECMO to treat neonatal respiratory failure unrespon-
sive to aggressive mechanical ventilatory support. These criteria 
attempt to define the population of neonates who have reversible 
causes of pulmonary hypertension and respiratory failure 15 • This 
does not include those neonates in whom ECMO might function 
as temporizing therapy, such as being a bridge to cardiac transplant, 
or a cardiac reconstructive procedure, or for those in the pediatric 
Table 1. Criteria for treatment of neonates with ECMO. 
1 . gestational age > 35 weeks 
2. weight > 2 kilograms 
3. no structural cardiac disease 
4. no intracranial hemorrhage 
5. no severe coagulopathy 
6. <seven days of assisted ventilation (relative limit) 
or < 10 days assisted ventilation (absolute limit) 
7. maximal ventilator management 
6. respiratory failure criteria (defined at each 
institution) 
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age group who might benefit from ECMOtherapy (near-drowning, 
pneumonia, etc). Current studies are attempting to determine the 
applicability and efficacy of ECMO in those populations. 
Overall survival of neonates on ECMO, including the various 
causes of neonatal pulmonary hypertension and respiratory failure 
as reported in the National Neonatal ECMO Registry, are listed in 
Table 2. Cumulative survival of the 3,500 neonates treated since 
1972 is 85% 1• These statistics are more impressive when it is noted 
that criteria for ECMO therapy was based on parameters calculated 
to define a predicted 80% mortality with conventional mechanical 
ventilator management. 
The criteria used at UCLA are similar to those used across the 
nation at other centers (Table 3), although it should be noted that 
variability in the criteria exists among ECMO centers, based on 
their individual experiences 15 • It is also important to note that these 
are entry criteria for placing an infant on ECMO and are not criteria 
for transport to an ECMO center for the purpose of evaluation. 
Most centers report that the majority ofECMO candidates are 
transferred from other institutions to the center, an experience 
supported at UCLA where 94% of patients treated were transferred 
from other hospitals. 
The average age of neonates placed on ECMO at UCLA was 
56±36 hours, approximately 20 hours after admission to the 
Neonatal Intensive Care Unit. Although the usual en route trans-
port time to UCLA from the referring hospitals for these infants 
averaged less than 2 hours, many of the referral calls were actually 
initiated 12 to 24 hours prior to the actual transport of the patients. 
The time between consideration of ECMO at the transferring 
institution, acceptance of the referral call by the tertiary Neonatal 
Intensive Care facility and the actual arrival of the patient at UCLA 
was in some cases as long as 24 hours and within a 150-mile radius 
from UCLA Medical Center. Because of the short distances 
involved, this delay did not complicate initiation of ECMO 
treatment in most cases; however, longer, out-of-state transport 
with travel times more than 5 to 6 hours might have been more 
difficult. 
The evidence from literature supports early transport of 
acutely ill neonatal and pediatric patients to a regional neonatal 
intensive care unit after stabilization as the ideal; such a system 
maximizes survival in a variety of disease states9•16· 17 • This also has 
been shown to be true in the adult age group18· 19• 
It is impossible to predict at what rate an infant with pulmo-
Table 2. National ECMO Registry Center pooled survival data. 
PATHOLOGY NO. PATIENTS SURVIVAL% 
Meconium aspiration 1313 92.5 
RDS 517 83.2 
Diaphragmatic hernia 546 62.5 
Pneumonia/sepsis 366 76.8 
Air leak syndrome 10 60.0 
Cardiac 46 60.9 
Persistent fetal circulation 456 86.8 
Other 81 84.0 
(Continued on page 334) ~ 
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NEONATAL SURVIVAL (continued from page 333) 
Table 3. ECMO respiratory failure criteria as defined at UCLA. 
RESPIRATORY FAILURE CRITERIA AS DEFINEDATUCLA 
Alveolar arterial oxygen difference (AaD02) 
= barometric pressure - water vapor pressure 
(47 mm Hg)- (p02 + pC02) 
= (760 mm Hg)- (47 mm Hg)- (p02 + pC02) 
Oxygenation index (01) 
= Fi02 x p02 divided by mean airway pressure 
CALCULATIONS PREDICTIVE OF A >80% MORTALITY3 
AaD02 
>61 0 mm Hg for 8 hours, 
or >605 mm Hg with a PIP >38 em H20 for 4 hours 
Oxygenation index. (01) >0.4 
nary hypertension and respiratory failure will deteriorate. How-
ever, the success treatment with ECMO is as much affected by 
early referral and expedient transport before the baby actually 
meets ECMO criteria as it is by reason of the severity of the 
respiratory failure. The neonate we report tolerated ECM 0 therapy 
without complication, survived her respiratory insult and did 
extremely well in follow-up in great part because of early aggres-
sive therapy and early transport by the neonatology service in 
Hawaii, before the need for ECMO was clearly defined. 
A regional ECMO Center in Hawaii would obviate the need 
for long-distance transport, but it would require a significant start-
up cost (estimated at $250,000) and would require physician, 
technician and nursing bedside support continuously for the entire 
(average 120 hours) ECMO therapy duration. In addition, it has 
been recommended that such centers treat a minimum of 2 to 3 
neonates per month in order to maintain the competence and 
certification of the ECMO personnel, and in order to justify the 
costs of running and maintaining an ECMO program. Currently 
the need for ECMO in the State of Hawaii may not justify the 
creation of a regional ECMO referral center; however, as the 
health care system in the Pacific Basin develops, with Hawaii in 
a geographically centralized position, this need may change and a 
Hawaii Regional ECMO Referral Center may become necessary. 
Until that time comes, it can be shown that long-distance transport 
of severely ill neonates with pulmonary hypertension and respira-
tory failure is feasible using currently available transport systems. 
Excellent patient outcomes are expected, given early referral and 
aggressive stabilization pre-flight. 
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"You don't need to worry 'bout Daddy and me ... 
we're living in a hotel now that the Health Inspector 
came and padlocked the house." 
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